TrialJournal of clinical microbiology2010

Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.

Deborah Watson-Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.